histidyl-aspartyl-glutamyl-leucine: HDEL intracellular distribution is characteristic of plant endoplasmic reticulum (ER) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 131113 |
| MeSH ID | M0208017 |
| Synonym |
|---|
| hdel sequence |
| l-leucine, n-(n-(n-l-histidyl-l-alpha-aspartyl)-l-alpha-glutamyl)- |
| histidyl-aspartyl-glutamyl-leucine |
| his-asp-glu-leu |
| n-(n-(n-l-histidyl-l-alpha-aspartyl)-l-alpha-glutamyl)-l-leucine |
| 129623-52-5 |
| DTXSID20156210 |
| (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoic acid |
| (s)-4-((s)-2-((s)-2-amino-3-(1h-imidazol-4-yl)propanamido)-3-carboxypropanamido)-5-(((s)-1-carboxy-3-methylbutyl)amino)-5-oxopentanoic acid |
| AKOS040752021 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.35) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 17 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||